Botulinum Toxin in Facial Aesthetics Affects the Emotion Process: A Meta-analysis of Randomized Controlled Trials

Abstract

This study aimed to conduct a meta-analysis of randomized controlled trials (RCTs) to evaluate the effects of the btulinum toxin-A (BT-A) in patiets with mood disorders. PubMed, Scopus, Web of Science, Cochrane Library and LILACS were searched without restrictions up to July 2022. The PICOS strategy was used for the selection of studies and risk-of-bias assessment was performed using Cochrane's tool for RCTs. RCTs were included if they compared BT-A treatment on facial muscles in patients with mood disorders to placebo. After assessment of the full texts, seven studies were selected. Five studies had low risk of bias for the generation of random sequence and blinding of participants and professional domains. A total of four studies showed a low risk of bias for the allocation concealment and blinding of the evaluation of the domain results. The domain of selective reports showed a low risk of bias in all included studies. However, four studies presented a high risk of bias for the domain of other biases. The meta-analysis was based on the mean difference or standardized mean difference between the BT-A and placebo groups for each selected trial and revealed that the BT-A group showed a significant improvement in the symptoms of depression when compared to placebo. This study revealed that the BT-A application into mimic muscles of the upper third of the face improves the mood disorders, but it was not possible to guarantee whether the aesthetic benefits can contribute to reducing the severity of the depressive state.

Utilização da toxina botulínica no tratamento da depressão: Uma revisão integrativa

“…Evidências coletadas indicam que a toxina botulínica pode interferir na expressão e percepção das emoções, potencialmente influenciando a saúde mental dos pacientes. Esses achados sugerem que a toxina botulínica pode representar uma opção de tratamento eficaz não apenas para a depressão, mas também para outras desordens psiquiátricas, em adição aos seus usos estéticos e terapêuticos (De Sousa et al, 2023;Costa et al, 2022).…”

Toxina Botulínica e o processamento das emoções: uma revisão de literatura sobre os efeitos além da pele

“…Os estudos reforçam que a TB pode ser uma terapia sustentável para a depressão e que pode oferecer vantagens em termos de segurança e tolerabilidade em comparação a outros tratamentos antidepressivos. 39…”

Inflammatory Markers and Brain Volume in Patients with Post-traumatic Stress Disorder

“…Volumetric brain changes in multiple regions have been related to inflammation factors, especially in stress-related disorders [ 20 ]. According to several previous studies, there has been a positive correlation between inflammatory factors and brain volume [ 21 , 22 ].…”